Additional Treatment Related Costs. In addition to the Per-Subject Costs, CRO will pay Institution for the other Additional Treatment Related Costs as set forth in Exhibit 1. Institution shall submit requests for payment for Additional Treatment Related Costs in accordance with Section 11 (Invoices & Payments), including submission of any back-up documentation or receipts for pass- through expenses. Any costs designated as invoiceable in Exhibit 1 should be invoiced at the visits or timepoints specified therein and not submitted to third party insurance payors.
Additional Treatment Related Costs. In addition to the Per-Subject Costs, CRO will pay Institution for the other Additional Treatment Related Costs as set forth in Exhibit 1. Institution shall submit requests for payment for Additional Treatment Related Costs in accordance with Section 12 (Invoices & Payments), including submission of any back-up documentation or receipts for pass-through expenses. Any costs designated as invoiceable in Exhibit 1 3. Ďalšie náklady súvisiace s liečbou: Okrem nákladov na jedného účastníka zaplatí CRO inštitúcii aj ďalšie náklady súvisiace so skúšaním stanovené v Doložke č. 1. V súlade s článkom 12 (faktúry a platby) inštitúcia požiada o preplatenie týchto ďalších nákladov súvisiacich skúšaním a priloží k tomu podrobnú podpornú dokumentáciu alebo potvrdenky dokladajúce tieto priebežné výdaje. Akékoľvek náklady označené ako fakturovateľné v Doložke č. 1, musia byť should be invoiced at the visits or timepoints specified therein and not submitted to third party insurance payors. vyfakturované CRO pri návštevách alebo v časových bodoch špecifikovaných v Doložke č. 1 a nebudú fakturované tretím stranám - pojišťovniam.
Additional Treatment Related Costs. In addition to the Per-Subject Costs, CRO will pay Payee for the other Additional Treatment Related Costs as set forth in tables of Paymets bellow. Payee shall submit requests for payment for Additional Treatment Related Costs in accordance with Section 12 (Invoices & Payments), including submission of any back-up documentation or receipts for pass-through expenses. Any costs designated as invoiceable in Attachment A should be invoiced at the visits or timepoints specified therein and not submitted to third party insurance payors. 3.
Additional Treatment Related Costs. In addition to the Per-Subject Costs, CRO will pay Institution and Principal Investigator for the other Additional Treatment Related Costs as set forth in Exhibit 1. Institution and Principal Investigator shall submit requests for payment for Additional Treatment Related Costs in accordance with Section 13 (Invoices & Payments), including submission of any back-up documentation or receipts for pass-through expenses. Any costs designated as invoiceable in Exhibit 1 should be invoiced at the visits or timepoints specified therein and not submitted to third party insurance payors. 4. Další náklady spojené s léčbou: Kromě nákladů na subjekt bude CRO hradit Instituci a Hlavnímu zkoušejícímu i další náklady spojené s léčbou uvedené v příloze 1. Instituce a Hlavní zkoušející předloží žádost o úhradu dalších nákladů spojených s léčbou v souladu s článkem 13 (Faktury a platby), což zahrnuje například předložení průvodní dokumentace nebo účtů za průběžné výdaje. Náklady označené v příloze 1 jako fakturovatelné by měly být fakturovány při návštěvách nebo v termínech stanovených v této příloze a nikoli předkládány plátcům pojištění třetích stran.
Additional Treatment Related Costs. In addition to the Per-Subject Costs, Pfizer/CRO will pay Centerfor the other Additional Treatment Related Costs as set forth in Exhibit 1. centershall submit requests for payment for Additional Treatment Related Costs in accordance with Section 12 (Invoices & Payments), including submission of any back-up documentation or receipts for pass-through expenses. Any costs designated as invoiceable in Exhibit 1 should be invoiced at the visits or timepoints specified therein and not submitted to third party insurance payors.
Additional Treatment Related Costs. In addition to the Per-Subject Costs, CRO will pay Center/Investigator for the other Additional Treatment Related Costs as set forth in Exhibit 1. Center /Investigator shall submit requests for payment for Additional Treatment Related Costs in accordance with Section 12 (Invoices & Payments), including submission of any back-up documentation or receipts for pass-through expenses. Any costs designated as invoiceable in Exhibit 1 should be invoiced at the visits or timepoints specified therein and not submitted to third party insurance payors. uvedených v tomto dodatku a nesmí být předkládány nezávislým plátcům pojištění.
